Close

180 Life Sciences Corp (ATNF) Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Jun 14, 2022 04:15PM
Celltrion Healthcare and 180 Life Sciences (ATNF) Enter MOU for Supply Agreement for Ongoing Supply of Drug for Anti-TNF Product Trials for Novel Indications Sep 20, 2021 08:01AM
180 Life Sciences Corp (ATNF) announces availability of broadcast titled, "Controlling Inflammation to Stop Disease" Mar 26, 2021 08:38AM